THE HEALTH PRESS DAILY

A recently published market research report has been added to the repository of Mart Research is an in-depth analysis of Global Food Supplements Market. Based on a historical growth analysis and current scenario of the Nutritional Supplements market, the report aims to provide actionable insights into the global market growth forecast. The authenticated data presented in the...

Who doesn't love a good tax deduction? As a small business owner, you should LOVE them, but often small business owners trying to control their own tax journey can overlook expenses that are tax-deductible. It's pretty easy to identify your obvious business expenses (payroll, rent, printer paper) as tax deductions, but there are some less obvious deductions...

The "fit" in Hockey FIT stands for fans in training. The program, which emerged from a 2014 Western University pilot, encourages those who share a passion for their local ice hockey...

It's amazing to see that we already have a full quarter of 2021 behind us - as the year goes by! This month we are excited again to highlight some of the outstanding contributions from the Diabetes Online Community (DOC). With the return of the sports world amid the ongoing pandemic, March Madness was back. In keeping...

Published: An hour ago Author: Ashwin Naphade Category: #news ...

March 31, 2021 3 min read ...

NEW YORK, March 31, 2021 / PRNewswire / - A panel of the National Advertising Review Board (NARB), the professional bar association of BBB National Programs, has recommended doTERRA International, LLC that the requirement of "Certified Pure Therapeutic Grade" and the use of the term "Therapeutic Quality" be recommended Description of doTERRA products. The NARB Panel's recommendation extends to claims...

1/2 Fitness Elite owner Kristen Pappalardo. PHOTO Courtesy of the Fitness Elite 2/2 Fitness Elite's Fit Elite Movement fourth annual fundraiser raised $ 3,053.40 for...

Regeneron Pharmaceuticals has reported initial results from the Protocol W study of Eylea (aflibercept) injection, which found a 68% reduced risk of developing vision-threatening complications in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR) of the center showed diabetic...